SEC Form 4 · accession 0000905148-18-000920

REATA PHARMACEUTICALS INC · RETA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

CPMG Inc

Director · 10% Owner

Period of report

Dec 10, 2018

Accepted (ET)

Dec 12, 2018 · 5:57 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001358762

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Class A common stock^F2,F1	Dec 10, 2018	P	26,174	$57.9329	A	26,174	I	By Nighthawk Partners, LP
Class A common stock^F3,F1	Dec 10, 2018	P	1,078	$58.6218	A	27,252	I	By Nighthawk Partners, LP
Class A common stock^F4,F1	Dec 10, 2018	P	29,347	$59.5303	A	56,599	I	By Nighthawk Partners, LP
Class A common stock^F5,F1	Dec 11, 2018	P	52,809	$60.0719	A	109,408	I	By Nighthawk Partners, LP
Class A common stock^F6,F1	Dec 12, 2018	P	1,418	$59.8952	A	281,918	I	By Willet Fund, LP
Class A common stock^F1	holding	—	—		—	44,200	I	By Barred Owl Partners, LP
Class A common stock^F1	holding	—	—		—	34,897	I	By Managed Account for Trustees of the University of Pennsylvania
Class A common stock^F1	holding	—	—		—	442,560	I	By Gallopavo, LP
Class A common stock^F1	holding	—	—		—	748,253	I	By Roadrunner Fund, LP
Class A common stock^F1	holding	—	—		—	103,185	I	By Blackwell Partners LLC
Class A common stock^F1	holding	—	—		—	431,155	I	By Yellow Warbler, LP
Class A common stock^F1	holding	—	—		—	110,640	I	By Killdeer Fund, LP
Class A common stock^F1	holding	—	—		—	109,415	I	By Mallard Fund, LP
Class A common stock^F1	holding	—	—		—	37,909	I	By Crested Crane, LP
Class A common stock^F1	holding	—	—		—	63,481	I	By Flamingo Fund, LP
Class A common stock^F1	holding	—	—		—	334,740	I	By Sandpiper Fund, LP
Class A common stock^F1	holding	—	—		—	160,265	I	By Kestrel Fund, LP
Class A common stock^F1	holding	—	—		—	11,076	I	By CD Fund, LP
Class A common stock^F1	holding	—	—		—	134	I	By Redbird Life Sciences Partners, LP
Class A common stock	holding	—	—		—	113	D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses

F1The Reporting Person is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Blackwell Partners LLC; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; and a managed account for Trustees of the University of Pennsylvania. The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
F2This price reflects the weighted average purchase price for open-market purchases on December 10, 2018, within a $1.00 range. The actual prices for these transactions range from $57.235 to $58.23, inclusive. The Reporting Person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares purchased at each separate price within the ranges set forth in footnotes (2) through (6) to this Form 4.
F3This price reflects the weighted average purchase price for open-market purchases on December 10, 2018, within a $1.00 range. The actual prices for these transactions range from $58.235 to $59.17, inclusive.
F4This price reflects the weighted average purchase price for open-market purchases on December 10, 2018, within a $1.00 range. The actual prices for these transactions range from $59.24 to $59.80, inclusive.
F5This price reflects the weighted average purchase price for open-market purchases on December 11, 2018, within a $1.00 range. The actual prices for these transactions range from $59.52 to $60.145, inclusive.
F6This price reflects the weighted average purchase price for open-market purchases on December 12, 2018, within a $1.00 range. The actual prices for these transactions range from $59.84 to $59.98, inclusive.

Remarks

Mr. McGaughy, Jr., a co-director and co-shareholder of the Reporting Person, serves on the Issuer's Board of Directors (the "Board") as a representative of the Reporting Person. By virtue of his representation on the Board, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the Reporting Person is deemed to be a director by deputization.